10:51:18 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-18 Bokslutskommuniké 2024
2024-11-19 Kvartalsrapport 2024-Q3
2024-08-20 Kvartalsrapport 2024-Q2
2024-06-07 Ordinarie utdelning CALMA B 0.00 SEK
2024-06-05 Årsstämma 2024
2024-05-21 Kvartalsrapport 2024-Q1
2024-02-20 Bokslutskommuniké 2023
2023-12-14 Extra Bolagsstämma 2023
2023-11-21 Kvartalsrapport 2023-Q3
2023-08-22 Kvartalsrapport 2023-Q2
2023-05-23 Kvartalsrapport 2023-Q1
2023-05-17 Ordinarie utdelning CALMA B 0.00 SEK
2023-05-16 Årsstämma 2023
2023-02-21 Bokslutskommuniké 2022
2022-11-22 Kvartalsrapport 2022-Q3
2022-09-22 Extra Bolagsstämma 2022
2022-08-23 Kvartalsrapport 2022-Q2
2022-05-24 Kvartalsrapport 2022-Q1
2022-05-19 Ordinarie utdelning CALMA B 0.00 SEK
2022-05-17 Årsstämma 2022
2022-02-25 Bokslutskommuniké 2021
2022-02-23 Bokslutskommuniké 2021
2021-10-29 Kvartalsrapport 2021-Q3
2021-08-27 Kvartalsrapport 2021-Q2
2021-05-28 Kvartalsrapport 2021-Q1
2021-05-19 Ordinarie utdelning CALMA B 0.00 SEK
2021-05-18 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-12-23 Extra Bolagsstämma 2020
2020-11-25 Kvartalsrapport 2020-Q3
2020-08-27 Kvartalsrapport 2020-Q2
2020-05-20 Kvartalsrapport 2020-Q1
2020-05-15 Ordinarie utdelning CALMA B 0.00 SEK
2020-05-14 Årsstämma 2020
2020-02-28 Bokslutskommuniké 2019
2019-11-25 Kvartalsrapport 2019-Q3
2019-11-06 Extra Bolagsstämma 2019
2019-08-27 Kvartalsrapport 2019-Q2
2019-05-23 Kvartalsrapport 2019-Q1
2019-05-10 Ordinarie utdelning CALMA B 0.00 SEK
2019-05-09 Årsstämma 2019
2019-02-28 Bokslutskommuniké 2018
2018-11-26 Kvartalsrapport 2018-Q3
2018-08-27 Kvartalsrapport 2018-Q2

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Calmark Sweden är verksamt inom medicinteknik. Bolaget specialiserar sig inom utveckling av diagnostiska verktyg riktade mot nyfödda barn. Tekniken utgår ifrån den egenutvecklade plattformen och används för analys de första veckorna efter födseln. Instrumentet används som biomarkör för att studera blodvärden. Störst verksamhet återfinns inom den nordiska marknaden. Bolaget grundades under 2007 och har sitt huvudkontor i Karlstad.
2021-02-04 09:52:49

Calmark Sweden AB has hired Annika Kaisdotter Andersson for the role as International Quality Manager in order to strengthen its QA/RA capabilities. Annika is currently working as Global Head of Quality Assurance in the ABB group. She will work on Calmark's quality management system and product registrations together with Michael Lundh, who joined the team last summer.

Annika Kaisdotter Andersson has a wealth of experience in the quality management of both small and large companies. Prior to joining ABB, she worked as Manager Operations & Quality at Hök Instrument AB and Senseair. Annika holds a Ph.D. in Electronics/Biomedical engineering, and the product developed and launched by Hök Instrument was based on her Ph.D. thesis[1] on breath alcohol analysis. For three years, Annika Kaisdotter Andersson was Vice President of the company, where she took part in establishing the production and is one of the patent holders. 

"I first encountered Calmark in 2009 through the Go Global Medtech program, where the founders Mathias Karlsson and Sofia Hjort af Ornäs were among the participants. We have been in regular contact since Anna became the CEO, and I have followed the company's journey with great interest.  It is very inspiring to get the chance to join the team now, in this exciting and expansionary phase," says Annika Kaisdotter Andersson. "I hope that my broad background focused on quality will contribute to continued success for the company. It also warms my heart to get the opportunity to return to medtech!"

"It gives us immense satisfaction that we have been able to convince Annika to join Calmark," says Anna Söderlund, CEO. "In view of the forthcoming global launch, with a large number of registrations across continents, and with the IVDR coming into effect next year, it is essential for us to strengthen our QA/RA resources. We already have a high level of competence in this area, thanks to Micke Lundh, and Annika will complement the team very well with her extensive experience from a variety of industries. I really look forward to welcoming her to the team!"  

Annika Kaisdotter Andersson is a shareholder in Calmark Sweden AB and holds 45,808 B shares. She will take up position on April 12.

 

1 Improved Breath Alcohol Analysis with Use of Carbon Dioxide as the Tracer Gas https://pubmed.ncbi.nlm.nih.gov/20582483/
 

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.